iCAD, a company specializing in AI-powered cancer detection solutions, has announced a strategic agreement with Windsong Radiology Group. This partnership aims to implement iCAD’s ProFound AI Breast Health technology at Windsong Radiology’s locations in Western New York.
The ProFound AI Breast Health Suite is designed to enhance the accuracy and efficiency of mammography readings, aiming to reduce false positives and unnecessary biopsies. By providing a concurrent read of screening and diagnostic mammograms, this AI technology can aid radiologists in detecting breast cancer earlier.
Dana Brown, CEO of iCAD, expressed enthusiasm about the collaboration. “We are thrilled to work with US Radiology to extend our advanced mammography solutions to more patients. This agreement supports our mission to ensure that AI capabilities in cancer detection are accessible to all patients.”
Windsong Radiology, recognized for its commitment to clinical excellence in women’s imaging, is adopting iCAD’s advanced technology to further enhance its services. Dr. Raja Cheruvu, President of Windsong Radiology, stated, “We are dedicated to clinical excellence and continually bringing in innovations that improve our radiology services. We are excited to offer iCAD’s breast AI solutions to our community to stay at the forefront of breast cancer detection and treatment.”
Gerry Lewis, Chief Information Officer of US Radiology Specialists, emphasized the significance of this integration. “Introducing iCAD’s ProFound AI Breast Health Suite into our screening services is a major advancement in our efforts to provide top-quality imaging services. This collaboration underscores our dedication to using next-generation technology to enhance patient outcomes.”